2008
DOI: 10.1016/j.transproceed.2008.05.072
|View full text |Cite
|
Sign up to set email alerts
|

Model for End-Stage Liver Disease (MELD) Score System to Evaluate Patients With Viral Hepatitis on the Waiting List: Better Than the Child-Turcotte-Pugh (CTP) System?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
10
1
2

Year Published

2009
2009
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 11 publications
2
10
1
2
Order By: Relevance
“…This finding is in agreement with previous studies reporting same relationship but with higher correlation coefficient values [32][33][34].…”
Section: Discussionsupporting
confidence: 94%
See 1 more Smart Citation
“…This finding is in agreement with previous studies reporting same relationship but with higher correlation coefficient values [32][33][34].…”
Section: Discussionsupporting
confidence: 94%
“…This finding is in agreement with Schnider et al [40]. However, many previous studies reported a significant decrease in PFV as the cirrhosis progressed [27], and with increasing CTP grades of severity of cirrhosis [15,26]; however, the portal blood flow remained normal because of enlarged portal caliber [34]. Also, KoK et al [36] described a reversed portal flow in patients with veno-occlusive disease and portosystemic shunts; and a decrease in the PFV in cirrhotic patients.…”
Section: Discussionsupporting
confidence: 92%
“…Recently, the MELD score has replaced the CP score in the United States for prioritizing liver donor allocation. Como et al (39) showed that the use of the MELD score produced an advantage for Hepatocellular Carcinoma (HCC), but about one in every 11 viral hepatitis patients may be harmed using this scoring system. …”
Section: Discussionmentioning
confidence: 99%
“…The INR has been accepted to standardize PT reporting in liver disease. However, kovacs [15] demonstrated that the INR system for patients with liver impairment is not valid.…”
Section: Discussionmentioning
confidence: 99%
“…The INR has been proposed [12] and is accepted routinely to standardize PT reporting in liver disease [12,[14][15][16][17], however, the ISIs used in the calculation of the INR is derived from a cohort of patients on stable oral anticoagulant, so the INR should only be applied to patients receiving stable oral anticoagulant therapy [18]. This is due to the difference in the mechanisms of the coagulation defects, in liver disease, most coagulation defects are caused by reduced synthesis of coagulation factors, whereas oral anticoagulation induces decarboxylated inactive protein production [19].…”
Section: Introductionmentioning
confidence: 99%